Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
14.60
+0.51 (3.62%)
Dec 5, 2025, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| Net Income | -81.89 | -116.05 | -133.82 | -121.76 | -79 | |
| Depreciation & Amortization | 4.59 | 2.34 | 2.37 | 2.97 | 3.33 | |
| Loss (Gain) From Sale of Assets | 0.01 | 0.02 | 0.15 | - | - | |
| Loss (Gain) From Sale of Investments | 0.5 | -1.14 | -2.93 | 0.33 | -1.91 | |
| Stock-Based Compensation | 18.57 | 26.8 | 28.22 | 26.97 | 20.99 | |
| Other Operating Activities | -0.95 | 2.14 | -5.17 | -0.08 | 0.28 | |
| Change in Accounts Receivable | -0.24 | 1.97 | 11.7 | 3.26 | -0.08 | |
| Change in Accounts Payable | -1.31 | -0.41 | -1.15 | -4.63 | 3.77 | |
| Change in Income Taxes | 32 | -1 | -2.29 | 8.54 | -24.21 | |
| Change in Other Net Operating Assets | 9.46 | 6.57 | -0.24 | -0.37 | 6.84 | |
| Operating Cash Flow | -19.27 | -78.76 | -103.15 | -84.78 | -70 | |
| Capital Expenditures | -12.9 | -17.95 | -9.06 | -2.13 | -0.75 | |
| Investment in Securities | 53.24 | 76.18 | -44.52 | 57.02 | 37.74 | |
| Investing Cash Flow | 40.35 | 58.24 | -53.58 | 54.9 | 36.99 | |
| Issuance of Common Stock | 0.15 | 0.15 | 2.21 | 21.26 | 3.61 | |
| Other Financing Activities | -26.76 | -27.77 | 195.92 | -1.23 | -0.53 | |
| Financing Cash Flow | -26.62 | -27.63 | 198.13 | 20.03 | 3.08 | |
| Net Cash Flow | -5.54 | -48.16 | 41.39 | -9.85 | -29.93 | |
| Free Cash Flow | -32.17 | -96.71 | -112.21 | -86.91 | -70.75 | |
| Free Cash Flow Margin | -49.24% | -142.99% | -141.67% | -100.87% | -72.88% | |
| Free Cash Flow Per Share | -1.51 | -4.57 | -5.35 | -4.22 | -3.51 | |
| Cash Interest Paid | 8.79 | 11.71 | 1.99 | - | - | |
| Cash Income Tax Paid | -33.68 | 0.24 | 4.9 | - | 0.03 | |
| Levered Free Cash Flow | -18.54 | -71.38 | -62.34 | -42.08 | -57.67 | |
| Unlevered Free Cash Flow | -13.74 | -64.55 | -59.13 | -42.08 | -57.67 | |
| Change in Working Capital | 39.91 | 7.13 | 8.02 | 6.79 | -13.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.